Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Solugel
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : University of Arkansas
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Solugel is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis, Knee.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 21, 2023
Lead Product(s) : Solugel
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : University of Arkansas
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Collagen
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : Florida State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Collagen Peptide Supplementation and Lifelong Athletes
Details : Collagen is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 02, 2023
Lead Product(s) : Collagen
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : Florida State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
